Related Articles
Clinical observation of gefitinib as a first-line therapy in sixty-eight patients with advanced NSCLC
Stereotactic radiotherapy in intrahepatic cholangiocarcinoma: A systematic review
Therapeutic effect and adverse reaction of sorafenib in the treatment of advanced renal cancer
Efficacy and safety of TACE combined with tyrosine kinase inhibitors and camrelizumab for unresectable hepatocellular carcinoma: A systematic review and meta‑analysis
A single-center experience of sorafenib monotherapy in patients with advanced intrahepatic cholangiocarcinoma